Saul Blecker1, Robert Herbert, Frederick L Brancati. 1. Division of General Internal Medicine, New York University School of Medicine, New York, New York 10016, USA. saul.blecker@nyumc.org
Abstract
BACKGROUND: Diabetes is associated with increased risk of mortality in heart failure. We examined the association of diabetes with expenditures, hospitalizations, and procedures among Medicare beneficiaries with heart failure during the last 6 months of life. METHODS AND RESULTS: In a 5% national Medicare sample, the prevalence of diabetes was 41.7% among 16,613 beneficiaries who died in 2007 with a diagnosis of heart failure. Diabetes was associated with higher expenditures during the last 6 months of life (mean $39,042 vs $29,003; P < .001), even after adjusting for covariates, including age, sex, race, geographic location, comorbidities, and preceding hospitalizations (cost ratio 1.08, 95% CI 1.05-1.12). For both diabetic and nondiabetic adults, more than one-half of Medicare expenditures were related to hospitalization costs (mean $22,516 vs $15,721; P < .001). Compared with their counterparts without diabetes, beneficiaries with diabetes had higher rates of hospitalization (adjusted incidence rate ratio 1.09, 95% CI 1.05-1.12) and days spent in the intensive care unit. CONCLUSIONS: Comorbid diabetes was common in heart failure and associated with higher expenditures, much of which was driven by increased rates of hospitalizations. Programs that focus on prevention of hospitalizations may reduce the substantial costs associated with heart failure near the end of life.
BACKGROUND:Diabetes is associated with increased risk of mortality in heart failure. We examined the association of diabetes with expenditures, hospitalizations, and procedures among Medicare beneficiaries with heart failure during the last 6 months of life. METHODS AND RESULTS: In a 5% national Medicare sample, the prevalence of diabetes was 41.7% among 16,613 beneficiaries who died in 2007 with a diagnosis of heart failure. Diabetes was associated with higher expenditures during the last 6 months of life (mean $39,042 vs $29,003; P < .001), even after adjusting for covariates, including age, sex, race, geographic location, comorbidities, and preceding hospitalizations (cost ratio 1.08, 95% CI 1.05-1.12). For both diabetic and nondiabetic adults, more than one-half of Medicare expenditures were related to hospitalization costs (mean $22,516 vs $15,721; P < .001). Compared with their counterparts without diabetes, beneficiaries with diabetes had higher rates of hospitalization (adjusted incidence rate ratio 1.09, 95% CI 1.05-1.12) and days spent in the intensive care unit. CONCLUSIONS: Comorbid diabetes was common in heart failure and associated with higher expenditures, much of which was driven by increased rates of hospitalizations. Programs that focus on prevention of hospitalizations may reduce the substantial costs associated with heart failure near the end of life.
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2009-12-17 Impact factor: 29.690
Authors: Andrea C Kronman; Arlene S Ash; Karen M Freund; Amresh Hanchate; Ezekiel J Emanuel Journal: J Gen Intern Med Date: 2008-05-28 Impact factor: 5.128
Authors: Hillary R Bogner; Steven D Miller; Heather F de Vries; Sumedha Chhatre; Ravishankar Jayadevappa Journal: J Card Fail Date: 2010-03-06 Impact factor: 5.712
Authors: Shannon M Dunlay; Nilay D Shah; Qian Shi; Bruce Morlan; Holly VanHouten; Kirsten Hall Long; Véronique L Roger Journal: Circ Cardiovasc Qual Outcomes Date: 2010-12-07
Authors: Lawrence Liao; Kevin J Anstrom; John S Gottdiener; Paul A Pappas; David J Whellan; Dalane W Kitzman; Gerard P Aurigemma; Daniel B Mark; Kevin A Schulman; James G Jollis Journal: Am Heart J Date: 2007-02 Impact factor: 4.749
Authors: Mark J Russo; Annetine C Gelijns; Lynne W Stevenson; Bhaven Sampat; Keith D Aaronson; Dale G Renlund; Deborah D Ascheim; Kimberly N Hong; Mehmet C Oz; Alan J Moskowitz; Eric A Rose; Leslie W Miller Journal: J Card Fail Date: 2008-07-21 Impact factor: 5.712
Authors: Marita G Titler; Gwenneth A Jensen; Joanne McCloskey Dochterman; Xian-Jin Xie; Mary Kanak; David Reed; Leah L Shever Journal: Health Serv Res Date: 2008-04 Impact factor: 3.402
Authors: Alan B Storrow; Cathy A Jenkins; Wesley H Self; Pauline T Alexander; Tyler W Barrett; Jin H Han; Candace D McNaughton; Benjamin S Heavrin; Mihai Gheorghiade; Sean P Collins Journal: JACC Heart Fail Date: 2014-04-30 Impact factor: 12.035
Authors: Bosco Baron-Franco; Gary McLean; Frances S Mair; Veronique L Roger; Bruce Guthrie; Stewart W Mercer Journal: Br J Gen Pract Date: 2017-04-10 Impact factor: 5.386
Authors: Phuong Bich Tran; Joseph Kazibwe; Georgios F Nikolaidis; Ismo Linnosmaa; Mieke Rijken; Josefien van Olmen Journal: BMC Med Date: 2022-07-19 Impact factor: 11.150
Authors: Maria Schletzbaum; Xing Wang; Robert Greenlee; Megan E Piper; Christie M Bartels Journal: Arthritis Care Res (Hoboken) Date: 2021-05 Impact factor: 4.794
Authors: H Wei; M M Averill; T S McMillen; F Dastvan; P Mitra; S Subramanian; C Tang; A Chait; R C Leboeuf Journal: Nutr Diabetes Date: 2014-02-24 Impact factor: 5.097
Authors: Erin K Donaho; Andrea C Hall; Jennifer A Gass; Macarthur A Elayda; Vei-Vei Lee; Shreda Paire; Deborah E Meyers Journal: J Am Heart Assoc Date: 2015-12-23 Impact factor: 5.501